These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29064651)

  • 41. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury.
    Chen G; Liao L; Li Y
    Int Urol Nephrol; 2015 Mar; 47(3):451-5. PubMed ID: 25609546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The probability of re-treatment after discontinuation of a 3-month versus a 6-month course of solifenacin for female overactive bladder: A prospective randomized controlled study.
    Hsiao SM; Chang TC; Lin HH
    Maturitas; 2019 Aug; 126():11-17. PubMed ID: 31239111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous Tibial Nerve Stimulation in the Office Setting: Real-world Experience of Over 100 Patients.
    Sirls ER; Killinger KA; Boura JA; Peters KM
    Urology; 2018 Mar; 113():34-39. PubMed ID: 29196071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of the percutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms].
    Kozma B; Majoros A; Pytel Á; Póka R; Takács P
    Orv Hetil; 2018 Oct; 159(43):1735-1740. PubMed ID: 30346235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
    Sherif H; Khalil M; Omar R
    Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial.
    Kinjo M; Sekiguchi Y; Yoshimura Y; Nutahara K
    Low Urin Tract Symptoms; 2018 May; 10(2):148-152. PubMed ID: 27911988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of Short Term Percutaneous Tibial Nerve Stimulation for Non-neurogenic Overactive Bladder Syndrome in Adults: A Meta-analysis.
    Wibisono E; Rahardjo HE
    Acta Med Indones; 2015 Jul; 47(3):188-200. PubMed ID: 26586384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?
    Tubaro A; Puccini F; De Nunzio C
    Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous Tibial Nerve Stimulation in Diabetic and Nondiabetic Women With Overactive Bladder Syndrome: A Retrospective Cohort Study.
    Zeno A; Handler SJ; Jakus-Waldman S; Yazdany T; Nguyen JN
    Female Pelvic Med Reconstr Surg; 2021 Nov; 27(11):686-690. PubMed ID: 34608031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2-year follow-up of positive responders.
    Yoong W; Shah P; Dadswell R; Green L
    Int Urogynecol J; 2013 May; 24(5):795-9. PubMed ID: 22955253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women.
    Kosilov KV; Loparev SA; Ivanovskaya MA; Kosilova LV
    Urol Int; 2014; 93(4):470-3. PubMed ID: 25170796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of solifenacin succinate tablets versus solifenacin succinate tablets with local estrogen for the treatment of overactive bladder in postmenopausal women--a multicenter, randomized, open-label, controlled comparison study.
    Jiang F; Zhu L; Xu T; Gong MY; Huang YL; Li HF; Wang JJ; Tong XW; Cheng XX; Bai WP; Li X; Xu XX; Xu HC
    Menopause; 2016 Apr; 23(4):451-7. PubMed ID: 26757270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study.
    Vecchioli Scaldazza C; Morosetti C
    Urol Int; 2016; 97(3):325-329. PubMed ID: 27092789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome.
    Gungor Ugurlucan F; Onal M; Aslan E; Ayyildiz Erkan H; Kizilkaya Beji N; Yalcin O
    Gynecol Obstet Invest; 2013; 75(1):46-52. PubMed ID: 23171636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initial Use of High-Dose Anticholinergics Combined with Alpha-Blockers for Male Lower Urinary Tract Symptoms with Overactive Bladder: A Prospective, Randomized Preliminary Study.
    Lee KW; Hur KJ; Kim SH; Cho SY; Bae SR; Park BH; Lee YS; Han CH; Kim HW
    Low Urin Tract Symptoms; 2017 Sep; 9(3):129-133. PubMed ID: 27028190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.
    Cornu JN; Hashim H; Van Der Aa F; De Nunzio C; Perez VG; Ferreira R; Elterman DS
    Can J Urol; 2023 Dec; 30(6):11756-11761. PubMed ID: 38104335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.